BioSpace News Archive

BioMidwest

Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2023

Daxor Corporation announces it will be attending the Annual Scientific Meeting of the Heart Failure Society of America which brings together the world’s leading experts in heart failure at the Huntington Convention Center in Cleveland, Ohio from October 6-9, 2023.

September 27, 2023

·

4 min read

Genetown

Amolyt Pharma to Present Data on the Renal Effects of Eneboparatide, a PTHR1 Agonist in Phase 3 for the Treatment of Hypoparathyroidism, at the 39th Congress of the French Society of Endocrinology

Amolyt Pharma today announced that it will present data on eneboparatide, the company’s investigational lead product candidate for the treatment of hypoparathyroidism, at the 39th Congress of the French Society of Endocrinology, being held October 4-7, 2023, in Marseille, France.

September 27, 2023

·

3 min read

Pharm Country

Indaptus Therapeutics to Present at the LD Micro Main Event XVI

Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will present a corporate overview at the LD Micro Main Event XVI.

September 27, 2023

·

6 min read

Biotech Beach

Cidara Therapeutics to Present New Data on Novel drug-Fc conjugate CD388 at IDWeek 2023

Cidara Therapeutics, Inc. today announced that it will present new data on its drug-Fc conjugate (DFC) candidate, CD388, in an oral presentation and two poster presentations at IDWeek 2023.

September 27, 2023

·

4 min read

Genetown

Akari Therapeutics to Present at Emerging Growth Conference

Akari Therapeutics, Plc today announced that the company will participate in the Emerging Growth Conference being held October 4 and 5, 2023.

September 27, 2023

·

4 min read

Pharm Country

Vaccinex to Present Update on PDAC/Pepinemab Study; New ActivMAb® Application

Vaccinex, Inc today announced that it will present data on a new ActivMAb® application on September 28th and an update on the Phase 1b/2 pepinemab study in patients with PDAC on September 29th.

September 27, 2023

·

7 min read

Pharm Country

Verrica Pharmaceuticals to Host Virtual KOL Event Discussing the Approval of YCANTH™ (Cantharidin) Topical Solution for the Treatment of Molluscum on October 11, 2023

Verrica Pharmaceuticals Inc. today announced that it will host a virtual KOL event discussing the approval of YCANTH™ (cantharidin) topical solution for the treatment of molluscum contagiosum on Wednesday, October 11, 2023 at 11:00 AM ET. To register, click here.

September 27, 2023

·

8 min read

Job Trends

Femasys Inc. Expands FemBloc Pivotal Trial Enrollment Securing First Academic Site to Participate

Femasys Inc. today announced that it has activated enrollment for its pivotal FemBloc trial at its first academic site located in Brooklyn, New York.

September 27, 2023

·

5 min read

BioProtect Secures $28M to Commercialize its Biodegradable Balloon for Rectal Protection During Prostate Cancer Radiation Therapy

BioProtect Ltd, a private Med Tech company focused on providing innovative, biodegradable spacing solutions, announced today the successful close of a $28 million funding.

September 27, 2023

·

2 min read

Business

Viatris and Ocuphire Pharma Announce FDA Approval of RYZUMVl™ (Phentolamine Ophthalmic Solution)

Viatris Inc. and Ocuphire Pharma, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved RYZUMVI™.

September 27, 2023

·

10 min read